← Back to search

INNOVATION PATHWAYS, LLC

PALO ALTO, CA, 94301

Unclaimed

Prime contracting experience

2 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
National Institutes of Health
THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULE—$3,608,865Jul 28, 2026Jul 1, 2023 – Jun 30, 2027
Prime
Department of Health and Human Services
National Institutes of Health
IGF::OT::IGF ACUTE RADIATION-INDUCED LUNG INJURY IN THE RHESUS MACAQUE AND ITS' TREATMENT BYIPW-5371, A SMALL MOLECULE INHIBITOR OF TGF# RECEPTOR-1 KINASE—$5,597,977Jan 18, 2024Apr 1, 2018 – Sep 30, 2023

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced
INNOVATION PATHWAYS, LLC – Palo Alto, CA | UEI NAHEV73JLXH3 | FedSub